These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 26239318

  • 1. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE, Kenney SP, Giménez-Lirola LG, Heffron CL, Matzinger SR, Opriessnig T, Meng XJ.
    Virus Res; 2015 Dec 02; 210():154-64. PubMed ID: 26239318
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T, Gomes-Neto JC, Hemann M, Shen HG, Beach NM, Huang Y, Halbur PG, Meng XJ.
    Microbiol Immunol; 2011 Dec 02; 55(12):863-73. PubMed ID: 21951266
    [Abstract] [Full Text] [Related]

  • 4. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T, O'Neill K, Gerber PF, de Castro AM, Gimenéz-Lirola LG, Beach NM, Zhou L, Meng XJ, Wang C, Halbur PG.
    Vaccine; 2013 Jan 07; 31(3):487-94. PubMed ID: 23174198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng XJ.
    J Virol; 2004 Jun 07; 78(12):6297-303. PubMed ID: 15163723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T, Shen HG, Pal N, Ramamoorthy S, Huang YW, Lager KM, Beach NM, Halbur PG, Meng XJ.
    Clin Vaccine Immunol; 2011 Aug 07; 18(8):1261-8. PubMed ID: 21653745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR, Opriessnig T, Xiao CT, Catanzaro N, Beach NM, Slade DE, Nitzel GP, Meng XJ.
    Virology; 2016 Nov 07; 498():82-93. PubMed ID: 27564544
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC, Bawa B, Serão NV, Trible BR, Kerrigan MA, Lunney JK, Dekkers JC, Rowland RR.
    Clin Vaccine Immunol; 2015 Dec 07; 22(12):1244-54. PubMed ID: 26446422
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of recombinant vaccinia virus vaccines co-expressing GP3/GP5 of European PRRSV and Cap protein of PCV2 in pigs.
    Han J, Ma H, Cao L, Jing J, Xiao P, Sun W, Xie C, Wen S, Li Y, Tian M, Lu H, Jin N.
    Appl Microbiol Biotechnol; 2018 Feb 07; 102(3):1145-1154. PubMed ID: 29189898
    [Abstract] [Full Text] [Related]

  • 16. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
    Bandrick M, Gutiérrez AH, Desai P, Rincon G, Martin WD, Terry FE, De Groot AS, Foss DL.
    Vet Immunol Immunopathol; 2020 May 07; 223():110034. PubMed ID: 32278900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
    Trible BR, Ramirez A, Suddith A, Fuller A, Kerrigan M, Hesse R, Nietfeld J, Guo B, Thacker E, Rowland RR.
    Vaccine; 2012 Jun 08; 30(27):4079-85. PubMed ID: 22521847
    [Abstract] [Full Text] [Related]

  • 20. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H, Qian P, Peng B, Shi L, Chen H, Li X.
    Vaccine; 2015 May 15; 33(21):2449-56. PubMed ID: 25863115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.